- Price
- $7.52
- Day
- -0.40%
- Mkt Cap
- $589.96M
- 52W Range
- $6.13 – $14.96
- Volume
- 639.5K
- Beta
- 1.48
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
PARSIPPANY, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the second quarter ended June 30, 2026, before the market opens on Thursday, August 13, 2026, and will host a corporate update conference call at 8:30am Eastern Time.
Read full article